Abstract:Objective To evaluate and compare the diagnostic value of magnetic resonance imaging T2 mapping and T1WI fatty score system in patients with Duchenne muscular dystrophy (DMD). Methods Twenty-seven patients with pathologically or gene proved DMD were enrolled in this study from November 2012 to June 2013.All the patients were male with an average age of 8.53±6.25 years,and the average course of disease was 4.17±3.79 years.Twelve healthy volunteers were recruited as the control group,including 7 male and 5 female,with an average age of 25.67 ±1.23 years.All subjects were underwent MRI examination of the lower extremities and MRI performance were evalulated.The T1 fat scoring system was used to classify the fat infiltration,and the T2mapping imaging was used to deteminre the T2value.The difference in T2 value was tested by independent sample t test between the patient and the control groups.Pearson correlation analysis was used to investigate the correlation between the T2values and T1fat score,and the correlation between two group with age,course of disease,and creatine kinase level.Spearman rank correlation analysis was used to explore the correlation between the T2value and the T1fat score with the clinical grade of the case group.Results In 22 patients,MRI showed a different degree of fatty infiltration in the affected muscles and the T1WI showed high signal.No abnormal MRI features were observed in five patients.The degree of involvement of the muscles varied.The T1fat score and T2value have similar distribution,both showing the most frequently involved muscle was the adductor magnus (T2value=243 ms,T1fat score=2.8),followed by the gluteus maximus(T2value=243 ms,T1fat score=2.7),vastus lateralis(T2value=225 ms,T1 fat score=1.9).The least affected muscle was the gracilis(T2value=171 ms,T1fat score=0.3),the sartorius muscle(T2value=170 ms,T1fat score=0.6),and the adductor longus (T2value=175 ms,T1fat score=0.4).The average T2value (211.9±65.2 ms)of the patients was significantly higher than that of the control group (141.6±16.7 ms) (t=5.228,P<0.001).The T2 value of the patients with normal MR features(158.1±15.4 ms)was mildly higher than that of control group(141.6±16.7 ms),but the difference was not statistically significant (t=1.89,P=0.078).The T2value was positively correlated with the T1 fat score,course of disease and clinical grade (all P<0.05),while was negatively correlated with age and creatine kinase value (all P>0.05).The T1fat score was positively correlated with age,course of disease,and clinical grade (all P<0.05),while was negative correlated with creatine kinase value (P>0.05).Conclusions T2mapping and T1fat scoring system both can well evaluate the distribution of muscle involvement and the severity of the disease in patients with Duchenne muscular dystrophy. The T2value is positively correlated with the T1fat score of the lower limb muscles in patients with Duchenne muscular dystrophy,while the T2value is more objective than T1fat score.

Five multivariate Duchenne muscular dystrophy progression models bridging six-minute walk distance and MRI relaxometry of leg muscles

Evaluating Genetic Modifiers of Duchenne Muscular Dystrophy Disease Progression Using Modeling and MRI

T2 Mapping and Fat Quantification of Thigh Muscles in Children with Duchenne Muscular Dystrophy

Concentric Exercise Effects on Skeletal Muscle Water T2 in Duchenne Muscular Dystrophy (P2.131)

New semi-automated tool for the quantitation of MR imaging to estimate in vivo muscle disease severity in mice

Utilization of Multi‐Parametric Quantitative Magnetic Resonance Imaging in the Early Diagnosis of Duchenne Muscular Dystrophy

Population longitudinal analysis of Gait Profile Score and North Star Ambulatory Assessment in children with Duchenne muscular dystrophy

Progression and Variation of Fatty Infiltration of the Thigh Muscles in Duchenne Muscular Dystrophy, a Muscle Magnetic Resonance Imaging Study

Distribution of MRI-derived T2 values as a biomarker for in vivo rapid screening of phenotype severity in mdx mice

Quantitative muscle magnetic resonance imaging in limb‐girdle muscular dystrophy type R1 (LGMDR1): A prospective longitudinal cohort study

Comprehensive quantitative magnetic resonance imaging assessment of skeletal muscle pathophysiology in golden retriever muscular dystrophy: Insights from multicomponent water T2 and extracellular volume fraction

Muscle Magnetic Resonance Imaging of Duchenne Muscular Dystrophy

Quantitative magnetic resonance imaging measures as biomarkers of disease progression in boys with Duchenne muscular dystrophy: a phase 2 trial of domagrozumab

327P Correlation of biomarkers and timed function tests in pediatric Becker muscular dystrophy

Assessment of Extracellular Volume Fraction in Becker Muscular Dystrophy by Using MR Fingerprinting

One-Year Longitudinal Assessment of Patients With CMT1A Using Quantitative MRI

Application of MR T2mapping in Patients with Duchenne Muscular Dystrophy

Multiomic characterization of disease progression in mice lacking dystrophin

Reductions in functional muscle mass and ability to ambulate in Duchenne muscular dystrophy from ages 4 to 24 years

Meaningful changes in motor function in Duchenne muscular dystrophy (DMD): A multi-center study

Development of an ultrasound‐based metric of muscle functional capacity for use in patients with neuromuscular disease